DR info

Clinical trials : 12 / Drugs : 11 - (DrugBank : 3) / Drug target gene : 1 - Drug target pathway : 1

Drugs and their primary sponsors and trial info

Combination of fish oil and colesevelam
   University of Manitoba
      2018   -   NCT01948648   Canada;
Comparator: ezetimibe
   Organon and Co
      2002   Phase 3   NCT00092833   United States;
Ezetimibe
   National Heart, Lung, and Blood Institute (NHLBI)
      2004   Phase 3   NCT00099996   United States;
   University of Manitoba
      2012   -   NCT01584206   Canada;
Ezetimibe + other lipid-lowering medication(s)
   Organon and Co
      2007   -   NCT00705211   -
      2007   -   NCT00704444   -
Ezetrol
   MSD SHARP & DOHME GMBH
      2004   -   EUCTR2004-001580-22-DE   Germany;United Kingdom;
   Merck Sharp & Dohme Ltd
      2004   -   EUCTR2004-001580-22-GB   Germany;United Kingdom;
MK-0653
   MSD SHARP & DOHME GMBH
      2004   -   EUCTR2004-001580-22-DE   Germany;United Kingdom;
   Merck Sharp & Dohme Ltd
      2004   -   EUCTR2004-001580-22-GB   Germany;United Kingdom;
MK0653, ezetimibe
   Organon and Co
      2004   Phase 3   NCT00092898   United States;
      2001   Phase 3   NCT00092820   -
      2001   Phase 3   NCT00092807   United States;
SCH-58235
   National Heart, Lung, and Blood Institute (NHLBI)
      2004   Phase 3   NCT00099996   United States;
      2001   Phase 2   NCT00045812   United States;
Sitosterol
   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
      2007   -   NCT00531128   United States;